Navigation Links
Wilson Sonsini Goodrich & Rosati Expands IP Litigation Practice

PALO ALTO, Calif., May 9, 2011 /PRNewswire/ -- Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, is pleased to announce that Jeffrey Alan Hovden has become a partner at the firm. An experienced intellectual property litigator and counselor with particular expertise in pharmaceuticals, Hovden formerly was a partner at Katten Muchin Rosenman. He will be based in the firm's New York office.


"In recent years, I'm proud to say that the firm has established one of the top generic pharmaceutical practices in the nation, with a unique integrated approach across a broad array of legal disciplines," said CEO Steve Bochner. "Jeff is a terrific IP litigator with exactly the type of knowledge and experience that our pharmaceutical clients most need and value. He will help us further grow the practice and lends additional strength to our overall East Coast litigation capabilities."

Hovden specializes in patent litigation with a focus on pharmaceutical cases under the Hatch-Waxman Act and within the biotechnology industry more broadly. He has litigated numerous patent infringement and invalidity actions, including many cases involving top-selling, global prescription drugs for both generic and name-brand pharmaceutical companies. In addition to his robust litigation practice, Hovden advises clients on their intellectual property portfolios. He has extensive experience with the Food, Drug, and Cosmetic Act's drug-approval provisions and their attendant regulations, and provides infringement, validity, and due diligence opinions. In addition, Hovden has experience with copyrights, particularly ones involving functional works, and counsels his biotechnology clients regarding licensing matters.

Prior to his tenure at Katten, Hovden was a partner at Frommer Lawrence & Haug. Conversant in Japanese, he received his J.D. from the Columbia University School of Law in 1993 and a B.A., summa cum laude, with majors in biology and philosophy from the University of Minnesota in 1988.

About Wilson Sonsini Goodrich & Rosati

Celebrating its 50th anniversary in 2011, Wilson Sonsini Goodrich & Rosati offers a broad range of services and legal disciplines focused on serving the principal challenges faced by the management and boards of directors of business enterprises. The firm is nationally recognized as a leader in the fields of corporate governance and finance, mergers and acquisitions, private equity, securities litigation, employment law, intellectual property, and antitrust, among many other areas of law. With long-standing roots in Silicon Valley, Wilson Sonsini Goodrich & Rosati has offices in Austin, Hong Kong, New York, Palo Alto, San Diego, San Francisco, Seattle, Shanghai, and Washington, D.C. For more information, please visit

SOURCE Wilson Sonsini Goodrich & Rosati
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PDL BioPharma Appoints Caroline Krumel as Vice President of Finance and Thanks Karen Wilson for her Contributions
2. Goodrich to Showcase Advanced Helicopter Systems at Heli-Expo
3. Lexicon Pharmaceuticals Announces Webcast of 2011 Annual R&D Day
4. American Regent Initiates Nationwide Voluntary Recall of Caffeine & Sodium Benzoate Injection, USP 250 mg/mL, 2 mL Single Dose Vial Due to Visible Particulates
5. ThermoGenesis Reports Third Quarter Fiscal 2011 Results; Major Progress Achieved in China & India
6. Pharmaceutical Litigation Partner James Stronski Joins Crowell & Moring
7. Reportlinker Adds European Market for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011
8. NMT Medical, Inc. Assigned All Its Assets to Joseph F. Finn, Jr., C.P.A. of the Firm Finn, Warnke & Gayton, LLP on April 20, 2011
9. Robbins & Myers Completes Sale of Romaco Businesses
10. Diplomat Specialty Pharmacys Hagerman Named Grant Thornton Leader & Innovator of the Year
11. Allina Hospitals & Clinics Makes Long Term Commitment to IOD
Post Your Comments:
(Date:11/25/2015)... announced the issue of United States patent No. 9,192,509  entitled: " Methods ... the company,s AVACEN 100 dry heat therapy medical device and specific methods of use, referred to ... Photo - ... ... ...
(Date:11/25/2015)... , Nov. 25, 2015 USP ... hazardous drug preparations (e.g. pharmacists, pharmacy technicians, nurses, ... veterinary technicians). The chapter also covers all entities ... (e.g., pharmacies, hospitals, other healthcare institutions, patient treatment ... --> --> What ...
(Date:11/25/2015)... Nov. 25, 2015  Mindray Medical ... MR ), a leading developer, ... worldwide, today announced that it will ... of shareholders at the Company,s Hong Kong office ... Prince Edward West Road, Mongkok KL, Hong ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... Privately ... has undertaken significant expansion of its current state of the art research, development ... PharmaTech’s strategy to increase its manufacturing capacity as well as to support its ...
(Date:11/25/2015)... ... November 25, 2015 , ... Many people know of the ... gain, cold hands, and dry skin. But many people who find their cholesterol levels ... regimen instead of their thyroid, especially if they don’t have any of the other ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... on providing comprehensive solutions involving adult stem cell therapies to patients with chronic ... the “Regenestem” name as a Registered Trademark (RTM). , Organizations are required to ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... prices in an early celebration of the early holiday shopping season. Starting Wednesday ... each (normally $33.95 ea). Black Friday promotional pricing is in addition to any ...
(Date:11/24/2015)... ... November 24, 2015 , ... Eric C. ... the many benefits of the revolutionary BIOLASE WaterLase iPlus 2.0™ system. This advanced ... traditionally used by a dentist in Gettysburg, PA . From routine visits ...
Breaking Medicine News(10 mins):